On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to ...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins and generating solid cash flows. The company reported FQ3 revenues of C$88 million and a ...

Shares of Aurora Cannabis and other cannabis companies saw significant buying on Wednesday following Aurora’s quarterly earnings report. For its most recent quarter, Aurora reported total net ...

Aurora Cannabis (ACB) stock jumped 45% on strong earnings, driven by record medical cannabis sales. CGC, TLRY and CRON also gained as the sector rallied on Aurora’s performance and trade tariff ...

Aurora Cannabis reported Q3 FY25 net revenue of CA$88.2M, driven by rise in medical cannabis sales and plant propagation. Adjusted EBITDA surged 316% to CA$23.1M, with adjusted gross margin ...

The term of the agreement is for three years with an option to extend and an estimated value of $27 million. EDMONTON — Aurora Cannabis signs a supply agreement with SNDL, a Canadian licensed ...

Institutional investors own 47.63% of the company’s stock. Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in ...